We are live on ! Find out more
BBNX

Beta Bionics

129 hedge funds and large institutions have $963M invested in Beta Bionics in 2025 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

176% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 21

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

46% more capital invested

Capital invested by funds: $659M → $963M (+$303M)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

11% more funds holding

Funds holding: 116129 (+13)

7.77% more ownership

Funds ownership: 103.45%111.22% (+7.8%)

Holders
129
Holders Change
+13
Holders Change %
+11.21%
% of All Funds
1.69%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
29
Increased
58
Reduced
21
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Barclays
51
Barclays
United Kingdom
$1.08M +$558K +31,734 +140%
N
52
Nuveen
North Carolina
$1.06M +$640K +36,446 +214%
AQR Capital Management
53
AQR Capital Management
Connecticut
$1.03M -$60.2K -3,423 -6%
Invesco
54
Invesco
Georgia
$968K +$570K +32,424 +199%
Verition Fund Management
55
Verition Fund Management
Connecticut
$940K +$32K +1,823 +4%
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$936K +$504K +28,678 +156%
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$843K +$331K +18,846 +80%
VFA
58
Values First Advisors
Tennessee
$804K -$36.9K -2,098 -5%
Jacobs Levy Equity Management
59
Jacobs Levy Equity Management
New Jersey
$775K +$685K +38,991 New
Tudor Investment Corp
60
Tudor Investment Corp
Connecticut
$767K +$678K +38,593 New
Deutsche Bank
61
Deutsche Bank
Germany
$755K +$428K +24,345 +178%
Ameriprise
62
Ameriprise
Minnesota
$705K +$259K +14,719 +71%
Jane Street
63
Jane Street
New York
$688K +$608K +34,614 New
EAM
64
Evanson Asset Management
California
$671K -$87.9K -5,000 -13%
Calamos Advisors
65
Calamos Advisors
Illinois
$642K +$568K +32,302 New
Wells Fargo
66
Wells Fargo
California
$635K +$298K +16,934 +113%
Two Sigma Advisers
67
Two Sigma Advisers
New York
$600K +$531K +30,200 New
QCM
68
Quantinno Capital Management
New York
$529K +$120K +6,840 +35%
GCM
69
Ghisallo Capital Management
Massachusetts
$497K -$439K -25,000 -50%
AllianceBernstein
70
AllianceBernstein
Tennessee
$487K -$2.97M -168,825 -87%
Voloridge Investment Management
71
Voloridge Investment Management
Florida
$464K +$410K +23,346 New
MIM
72
MetLife Investment Management
New Jersey
$451K +$252K +14,350 +171%
Renaissance Technologies
73
Renaissance Technologies
New York
$447K +$105K +6,000 +36%
Mariner
74
Mariner
Kansas
$425K +$376K +21,388 New
LPL Financial
75
LPL Financial
California
$418K +$79.9K +4,545 +28%

BBNX Hedge Fund Activity: Q3 2025 in Review

129 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q3 2025, worth a combined $963M — up 46% from $659M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new BBNX positions and 16 closed out — a net gain of 13 holders — while 58 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $33.8M. The largest seller was Perceptive Advisors, cutting an estimated $23.1M.

  • 129 institutional investors held Beta Bionics (BBNX) as of Q3 2025, up from 116 in Q2 2025.
  • Funds reported $963M of Beta Bionics stock for Q3 2025, up 46% quarter-over-quarter.
  • 29 funds opened new Beta Bionics positions in Q3 2025 and 16 closed out, a net change of +13 holders.
  • The largest Beta Bionics buyer in Q3 2025 was BlackRock, an estimated $33.8M added.
  • The largest Beta Bionics seller in Q3 2025 was Perceptive Advisors, an estimated $23.1M sold.

Based on aggregated 13F filings for Q3 2025.